PlainRecalls
FDA Devices Moderate Class II Terminated

VIDAS¿ CMV IgM 30 Tests

Reported: April 21, 2021 Initiated: March 16, 2021 #Z-1408-2021

Product Description

VIDAS¿ CMV IgM 30 Tests

Reason for Recall

bioMerieux received complaints about calibration issue observed on several lots of VIDAS¿ CMV IgM (ref 30205 ; 30205-01).

Details

Recalling Firm
Biomerieux Inc
Units Affected
18705 kits
Distribution
Distributed nationwide to NY, CA, IL, WV, NJ, NY, TX, IN, PA, WI, VA, GA, CO, MI, FL, OH, MA, LA, NV, MO, CT and internationally to Argentina, Australia, Belgium, Brazil, Switzerland, Chile, Colombia, Czech Republic, Germany, Egypt, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, India, Italy, Japan, South Korea, Mexico, Netherlands, Philippines, Poland, Portugal, Russian Fed., Sweden, Singapore, Thailand, Turkey, South Africa, Algeria, Angola, Bahrain, Belarus, Benin, Bolivia, Bosnia-Herz., Bulgaria, Burkina Faso, Cameroon, Cape Verde, Chad, Costa Rica, Croatia, Dem. Rep. Congo, Dominican Rep., Dutch Antilles, Ecuador, El Salvador, Georgia, Guatemala, Indonesia, Iran, Iraq, Israel, Kenya, Lebanon, Lithuania, Macedonia, Mali, Malta, Mongolia, Morocco, Mozambique, Nicaragua, Pakistan, Panama, Paraguay, Peru, Philippines, Qatar, Romania, Saudi Arabia, Senegal, Serbia, Slovenia, Sril Lanka, Syria, Tunisia, Uruguay, Utd.Arab Emir., Vietnam, Djibouti, Equatorial Guin, Zambia, Cap Verde
Location
Hazelwood, MO

Frequently Asked Questions

What product was recalled?
VIDAS¿ CMV IgM 30 Tests. Recalled by Biomerieux Inc. Units affected: 18705 kits.
Why was this product recalled?
bioMerieux received complaints about calibration issue observed on several lots of VIDAS¿ CMV IgM (ref 30205 ; 30205-01).
Which agency issued this recall?
This recall was issued by the FDA Devices on April 21, 2021. Severity: Moderate. Recall number: Z-1408-2021.